azacitidine has been researched along with ropivacaine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Fiegl, H; Fleischer, M; Hollmann, MW; Lirk, P; Weber, NC | 1 |
2 other study(ies) available for azacitidine and ropivacaine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro.
Topics: Amides; Anesthetics, Local; Antimetabolites, Antineoplastic; Azacitidine; Breast Neoplasms; Bupivacaine; Cell Survival; Decitabine; DNA Methylation; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Epigenesis, Genetic; Female; Humans; Lidocaine; MCF-7 Cells; Ropivacaine; Tumor Cells, Cultured | 2014 |